Chiarelli, N., Ritelli, M., Zoppi, N
The legal limit is 0.04% BAC or higher
Abstract Activation of endothelium and immune cells is fundamental to the initiation of autoimmune diseases such as rheumatoid arthritis (RA), and it results in trans-endothelial cell migration and synovial fibroblast proliferation, leading to joint destruction
(2017) 14:S32637
Tirzepatide has a half-life of approximately five days, meaning therapeutic levels decline gradually over several days to weeks after a missed injection rather than disappearing immediately
1 Mechanistically, treatment raised the Bcl-2/Bax ratio and reduced apoptosis markers (cleaved caspase-3 and PARP) in the dermal papilla cells, elevated VEGF production, and decreased TGF-1 secretion from dermal fibroblasts